Total Payments
$4,180
2024 Payments
$139.74
Companies
25
Transactions
201
Medicare Patients
1,077
Medicare Billing
$169,639
Payment Breakdown by Category
Food & Beverage$3,861 (92.4%)
Education$318.90 (7.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,861 | 195 | 92.4% |
| Education | $318.90 | 6 | 7.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $592.73 | 38 | $0 (2023) |
| Astellas Pharma US Inc | $508.86 | 12 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $396.13 | 22 | $0 (2020) |
| PFIZER INC. | $315.74 | 15 | $0 (2019) |
| Amgen Inc. | $299.70 | 13 | $0 (2020) |
| Gilead Sciences, Inc. | $253.89 | 15 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $239.71 | 20 | $0 (2019) |
| Boston Scientific Corporation | $238.43 | 5 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $217.50 | 13 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $214.18 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $139.74 | 6 | Philips North America LLC ($139.74) |
| 2023 | $22.91 | 1 | Novartis Pharmaceuticals Corporation ($22.91) |
| 2022 | $172.07 | 3 | Actelion Pharmaceuticals US, Inc. ($121.83) |
| 2020 | $204.69 | 10 | Janssen Pharmaceuticals, Inc ($76.80) |
| 2019 | $706.53 | 36 | PFIZER INC. ($182.13) |
| 2018 | $965.35 | 48 | E.R. Squibb & Sons, L.L.C. ($153.89) |
| 2017 | $1,969 | 97 | Astellas Pharma US Inc ($359.71) |
All Payment Transactions
201 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $27.36 | General |
| Category: Medical Device | ||||||
| 09/25/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $33.91 | General |
| Category: Medical Device | ||||||
| 08/15/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $26.26 | General |
| Category: Medical Device | ||||||
| 07/17/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $21.06 | General |
| Category: Medical Device | ||||||
| 06/04/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $22.15 | General |
| Category: Medical Device | ||||||
| 02/22/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $9.00 | General |
| Category: Medical Device | ||||||
| 02/15/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/14/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/11/2022 | BIOTRONIK INC. | Edora 8 DR-T (Device) | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/02/2022 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Cardiology | ||||||
| 08/18/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/17/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/20/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Cardiovascular | ||||||
| 04/06/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Cardiovascular | ||||||
| 03/06/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/24/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/21/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $31.75 | General |
| Category: Cardiology | ||||||
| 02/18/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Cardiovascular | ||||||
| 02/10/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/13/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/17/2019 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/03/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 11/27/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/15/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/01/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 144 | 161 | $37,930 | $11,333 |
| 2021 | 7 | 436 | 611 | $218,214 | $71,745 |
| 2020 | 7 | 497 | 838 | $285,214 | $86,561 |
Total Patients
1,077
Total Services
1,610
Medicare Billing
$169,639
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 62 | $18,228 | $7,063 | 38.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $12,460 | $3,418 | 27.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 69 | 71 | $7,242 | $852.55 | 11.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 137 | 218 | $61,912 | $25,075 | 40.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 91 | 165 | $62,370 | $24,570 | 39.4% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 64 | 72 | $61,062 | $14,240 | 23.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 40 | $7,800 | $2,943 | 37.7% |
| 93351 | Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report | Office | 2021 | 13 | 13 | $10,868 | $2,886 | 26.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 84 | 91 | $9,282 | $1,284 | 13.8% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2021 | 12 | 12 | $4,920 | $747.24 | 15.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 139 | 373 | $136,145 | $46,001 | 33.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 114 | 175 | $47,950 | $16,120 | 33.6% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 71 | 77 | $63,756 | $15,545 | 24.4% |
| 93351 | Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report | Office | 2020 | 15 | 15 | $12,105 | $3,470 | 28.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 29 | 40 | $7,520 | $2,800 | 37.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 116 | 144 | $14,112 | $2,282 | 16.2% |
| 0298T | Review and interpretation of external ekg recording for more than 48 hours up to 21 days | Office | 2020 | 13 | 14 | $3,626 | $344.06 | 9.5% |
About Dr. Stephen Arnold, M.D
Dr. Stephen Arnold, M.D is a Cardiovascular Disease healthcare provider based in San Pablo, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023021680.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Arnold, M.D has received a total of $4,180 in payments from pharmaceutical and medical device companies, with $139.74 received in 2024. These payments were reported across 201 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,861).
As a Medicare-enrolled provider, Arnold has provided services to 1,077 Medicare beneficiaries, totaling 1,610 services with total Medicare billing of $169,639. Data is available for 3 years (2020–2022), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location San Pablo, CA
- Active Since 08/14/2006
- Last Updated 04/14/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1023021680
Products in Payments
- ENTRESTO (Drug) $569.82
- XARELTO (Drug) $396.13
- ELIQUIS (Drug) $390.53
- Repatha (Biological) $244.64
- PRALUENT (Drug) $217.50
- BRILINTA (Drug) $214.18
- Lexiscan (Drug) $161.71
- VYNDAQEL (Drug) $150.42
- (5044) MCOT (Device) $139.74
- UPTRAVI (Drug) $121.83
- Letairis (Drug) $121.59
- JARDIANCE (Drug) $100.06
- PRALUENT ALIROCUMAB INJECTION (Biological) $93.14
- RESONATE (Device) $87.79
- ZIO Patch (Device) $66.23
- ADVANTIO (Device) $58.15
- SYNERGY (Device) $58.15
- Vascepa (Drug) $58.09
- Amplia MRI (Device) $55.55
- Corlanor (Drug) $55.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in San Pablo
Dr. Richard Stern, M.d, M.D
Cardiovascular Disease — Payments: $523,730
Cardiovascular Disease $523,730
Miss. Steven Anton, M.d, M.D
Cardiovascular Disease — Payments: $38,203
Cardiovascular Disease $38,203
Dr. David Weiland, M.d, M.D
Cardiovascular Disease — Payments: $14,272
Cardiovascular Disease $14,272
Dr. Gary Marcus, M.d, M.D
Cardiovascular Disease — Payments: $360.48
Cardiovascular Disease $360.48
Dr. David Hill, M.d, M.D
Cardiovascular Disease — Payments: $143.86
Cardiovascular Disease $143.86